This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Sandoz GmbH
Sandoz GmbH, a leading global player in the pharmaceutical industry, is headquartered in Austria (AT) and operates extensively across Europe, North America, and Asia. Founded in 1886, Sandoz has established itself as a pioneer in generic pharmaceuticals and biosimilars, focusing on high-quality, affordable medicines that enhance patient access to essential treatments. The company’s core offerings include a diverse range of generic medications, biosimilars, and over-the-counter products, distinguished by their rigorous quality standards and innovative approaches. Sandoz is recognised for its commitment to sustainability and patient-centric solutions, positioning itself as a trusted partner in healthcare. With a strong market presence and a history of significant milestones, Sandoz continues to lead in the development of accessible healthcare solutions worldwide.
DitchCarbon Score
How does Sandoz GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sandoz GmbH's score of 68 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sandoz GmbH, headquartered in Austria (AT), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Sandoz Group AG, which may influence its climate commitments and performance metrics. While Sandoz GmbH has not outlined specific reduction targets or initiatives, it is important to note that its climate strategies and commitments may be informed by the broader goals set by Sandoz Group AG. This includes potential targets cascaded from the parent company, which may involve frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). As a part of the pharmaceutical industry, Sandoz GmbH is likely to align with industry standards for sustainability and climate action, although specific commitments or achievements have not been detailed. The absence of reported emissions data suggests that the company may still be in the process of establishing or refining its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 75,620,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 158,430,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sandoz GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
